{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:41:42Z","timestamp":1775889702822,"version":"3.50.1"},"reference-count":27,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Limited data are available regarding optimal antimicrobial therapy for Staphylococcus aureus bacteremia (SAB) in pediatric patients. The purpose of this study was to assess clinical characteristics and outcomes associated with intravenous (IV) versus oral step-down treatment of pediatric SAB. This study evaluated patients aged 3 months to 18 years that received at least 72 h of inpatient treatment for SAB. The primary endpoint was 30-day readmission. Secondary endpoints included hospital length of stay and inpatient mortality. One hundred and one patients were included in this study. The median age was 7.9 years. Patients who underwent oral step-down were less likely to be immunocompromised and more likely to have community-acquired SAB from osteomyelitis or skin and soft tissue infection (SSTI). More patients in the IV therapy group had a 30-day readmission (10 (25.6%) vs. 3 (5.3%), p = 0.006). Mortality was low (5 (5%)) and not statistically different between groups. Length of stay was greater in patients receiving IV therapy only (11 vs. 7 days, p = 0.001). In this study, over half of the patients received oral step-down therapy and 30-day readmission was low for this group. Oral therapy appears to be safe and effective for patients with SAB from osteomyelitis or SSTIs.<\/jats:p>","DOI":"10.3390\/pharmacy10010016","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T20:45:21Z","timestamp":1642365921000},"page":"16","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population"],"prefix":"10.3390","volume":"10","author":[{"given":"Sarah Grace","family":"Gunter","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Grandview Medical Center, Birmingham, AL 35243, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Joyce B.","family":"Wingler","sequence":"additional","affiliation":[{"name":"Department of Antimicrobial Stewardship, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Cretella","sequence":"additional","affiliation":[{"name":"Department of Antimicrobial Stewardship, University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-7894","authenticated-orcid":false,"given":"Jamie L.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS 39216, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-3111","authenticated-orcid":false,"given":"Katie E.","family":"Barber","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS 39216, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-0137","authenticated-orcid":false,"given":"Kayla R.","family":"Stover","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS 39216, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e20170183","DOI":"10.1542\/peds.2017-0183","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in children","volume":"139","author":"Hamdy","year":"2017","journal-title":"Pediatrics"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Munro, A.P.S., Blyth, C.C., Campbell, A.J., and Bowen, A.C. (2018). Infection characteristics and treatment of Staphylococcus aureus bacteremia at a tertiary children\u2019s hospital. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3312-5"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jhin.2017.06.017","article-title":"The Scottish enhanced Staphylococcus aureus bacteremia surveillance programme: The first 18 months of data in children","volume":"97","author":"Murdoch","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/INF.0000000000001503","article-title":"The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection","volume":"36","author":"McNeil","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2018.13155","article-title":"Effect of algorithm-based therapy vs. usual care on clinical success and serious adverse events in patients with Staphylococcal bacteremia: A randomized clinical trial","volume":"320","author":"Holland","year":"2018","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/jac\/dky259","article-title":"Optimal treatment of MSSA bacteraemias: A meta-analysis of cefazolin versus antistaphylococcal penicillins","volume":"73","author":"Bidell","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jcpt.12743","article-title":"Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia","volume":"43","author":"Lewis","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1080\/14656566.2017.1403585","article-title":"Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia","volume":"18","author":"Gudiol","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1473-3099(10)70285-1","article-title":"Clinical management of Staphylococcus aureus bacteraemia","volume":"11","author":"Thwaites","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/INF.0000000000001635","article-title":"European Society for Pediatric Infectious Diseases practice guideline: Bone and joint infections","volume":"36","author":"Faust","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/jpids\/piy022","article-title":"Practice Patterns of Providers for the Management ofStaphylococcus aureus Bacteremia in Children: Results of an Emerging Infections Network Survey","volume":"7","author":"Wood","year":"2018","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/jpids\/piv009","article-title":"Does Bacteremia Associated With Bone and Joint Infections Necessitate Prolonged Parenteral Antimicrobial Therapy?","volume":"4","author":"Kallio","year":"2015","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bupha-Intr, O., Blackmore, T., and Bloomfield, M. (2020). Efficacy of Early Oral Switch with \u03b2-Lactams for Low-Risk Staphylococcus aureus Bacteremia. Antimicrob. Agents. Chemother., 64.","DOI":"10.1128\/AAC.02345-19"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciab156","article-title":"Intravenous to Oral Switch in Complicated Staphylococcus aureus Bacteremia Without Endovascular Infection: A Retrospective Single-Center Cohort Study","volume":"73","author":"Kouijzer","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/ciy916","article-title":"Early Oral Switch to Linezolid for Low-risk Patients with Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study","volume":"69","author":"Willekens","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1586\/14787210.2015.1063418","article-title":"Bacteremia in children: Epidemiology, clinical diagnosis and antibiotic treatment","volume":"13","author":"Pai","year":"2015","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prrv.2007.07.005","article-title":"Immunocompromised children: Conditions and infectious agents","volume":"8","author":"Kesson","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamapediatrics.2014.2822","article-title":"Comparative Effectiveness of Intravenous vs. Oral Antibiotics for Postdischarge Treatment of Acute Osteomyelitis in Children","volume":"169","author":"Keren","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","article-title":"Osteomyelitis-Septic Arthritis Study Group. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis in childhood","volume":"29","author":"Peltola","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_24","first-page":"218","article-title":"Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia","volume":"22","author":"Kumarachandran","year":"2017","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3947\/ic.2013.45.2.202","article-title":"Impact of methicillin-resistance on mortality in children and neonates with Staphylococcus aureus bacteremia: A meta-analysis","volume":"45","author":"Park","year":"2013","journal-title":"Infect. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus Intravenous Antibiotics for Bone and Joint Infection","volume":"380","author":"Li","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/10\/1\/16\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:39:40Z","timestamp":1760362780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/10\/1\/16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["pharmacy10010016"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy10010016","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]}}}